MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Basal ganglia"

  • 2016 International Congress

    Subthalamic nucleus activity during virtual reality provoked lower limb freezing in a patient with Parkinson’s disease and freezing of gait

    M.J. Georgiades, M. Gilat, J.M. Shine, J. McMaster, N. Mahant, S.J.G. Lewis (Sydney, Australia)

    Objective: Record subthalamic nucleus activity in a Parkinson's disease patient with gait freezing while they perform a virtual reality walking task during DBS surgery. Background:…
  • 2016 International Congress

    Apraxia in Parkinson’s disease

    M. Tábuas-Pereira, P. Correia, F. Moreira, A. Morgadinho, C. Januário (Coimbra, Portugal)

    Objective: We aim to study apraxia in Parkinson's disease. Background: Limb apraxia is a cognitive motor disorder of skilled, purposive movements not caused by elementary…
  • 2016 International Congress

    The small GTP-binding protein Rhes influences midbrain dopaminergic neurons: Behavioral and biochemical studies

    A. Pinna, F. Napolitano, G. Costa, P.F. Porceddu, L. Contu, J. Wardas, M.A. Casu, A. Usiello, M. Morelli (Cagliari, Italy)

    Objective: Rhes is a small GTP-binding protein highly enriched in the striatum, developmentally regulated by thyroid hormone, and by dopamine (DA) innervation in adult rat…
  • 2016 International Congress

    Attention to action: Common to both conversion (psychogenic) and Parkinsonian (neurogenic) motor speech disorders

    S. Sapir (Haifa, Israel)

    Objective: To review and present a common abnormality --- attention to action--- underlying Parkinsonian and conversion speech disorders. Background: Conversion speech disorders are characterized by…
  • 2016 International Congress

    A case of thalamic malignant glioma formation in a patient with STN-DBS for Parkinson’s disease

    A. Tomskiy, A. Gamaleya, N. Gubareva, Y. Latyshev, G. Kobyakov, L. Shishkina, I. Pronin (Moscow, Russia)

    Objective: We present a case of development of malignant glioma (glioblastoma multiforme) in the area adjacent to electrostimulation zone in a patient with chronic STN-DBS,…
  • 2016 International Congress

    Long term recordings of subthalamic ocillatory activity in patients with Parkinson’s disease

    W.J. Neumann, F. Staub, A. Horn, J. Schanda, G.H. Schneider, P. Brown, A.A. Kühn (Berlin, Germany)

    Objective: The aim of this study was to investigate the stability of beta oscillations (13 - 30 Hz) in the subthalamic nucleus (STN) of patients…
  • 2016 International Congress

    In-vivo free-water imaging and functional connectivity in a knock-in mouse model of DYT1 dystonia

    J.C. DeSimone, M. Febo, P. Shukla, E. Ofori, L.M. Colon-Perez, Y. Li, D.E. Vaillancourt (Gainesville, FL, USA)

    Objective: To examine in-vivo functional connectivity and free-water diffusion imaging in dystonic mutant Tor1a knock-in (DYT1) and wild-type (WT) control mice. We test the hypothesis…
  • 2016 International Congress

    Comparative study of the substantia nigra echogenicity and 123-I ioflupane SPECT in patients with REM behavior disorder

    J. Mašková, P. Dušek, D. Školoudík, K. Kupka, K. Šonka, V. Ibarburu Lorenzo Y Losada, J. Kubinyi, E. Ruzicka (Praha 2, Czech Republic)

    Objective: To compare (1) the echogenicity of substantia nigra (SN) in subjects with idiopathic REM behavior disorder (iRBD) and healthy controls and (2) to determine…
  • 2016 International Congress

    Striatal PDE10 expression in Parkinson’s disease (PD) and healthy controls using [18F]MNI-659 PET imaging

    D.S. Russell, D.L. Jennings, O. Barret, G.D. Tamagnan, D. Alagille, J.P. Seibyl, K.L. Marek (New Haven, CT, USA)

    Objective: To evaluate the feasibility of [18F]MNI-659 PET, a striatal PDE10A imaging tracer, as a imaging biomarker in PD. Background: PDE10 is highly and specifically…
  • 2016 International Congress

    Pallidal low frequency activity correlates with dystonic symptoms in patients with cervical dystonia

    W.J. Neumann, J. Huebl, C. Brücke, C. Slentz, G.H. Schneider, A.A. Kühn (Berlin, Germany)

    Objective: The aim of this study was to investigate the potential association between pallidal 4–12 Hz activity and symptom severity as quantified by the Toronto…
  • « Previous Page
  • 1
  • …
  • 18
  • 19
  • 20
  • 21
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley